Sarcoma Care Adherence and Survival in Strasbourg
ConditionSoft Tissue Sarcoma (STS)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Strasbourg, France
About this trial
This retrospective monocentric study evaluates adherence to international clinical practice guidelines for soft tissue sarcoma management in Strasbourg and its impact on overall survival. It also compares practices and outcomes between two periods (2010-2016 and 2017-2024).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient aged 18 years or older at first multidisciplinary tumor board presentation
Presented for multidisciplinary tumor board evaluation for soft tissue or visceral tumor
First presentation between 01/01/2017 and 31/12/2024
Absence of opposition to reuse of medical data for research purposes
Disqualifiers
Presence of opposition to reuse of medical data for research purposes
Patient younger than 18 years at first presentation
Bone tumors, gastrointestinal stromal tumors (GIST), or Kaposi sarcoma
First presentation outside the study period
Trial population
Adult patients with suspected or confirmed soft tissue sarcoma presented at multidisciplinary tumor boards in Strasbourg between 2017 and 2024
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Adherence to Good Clinical Practice and Overall Survival
Evaluation of adherence to international guidelines using DELPHI criteria and assessment of overall survival defined as time from diagnosis to death from any cause
Time frame
From diagnosis up to end of follow-up (2017-2024)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov